Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.

about

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.

Item

http://www.wikidata.org/entity/Q40566915

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.

@en

type

Item

label

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.

@en

prefLabel

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.

@en

P1476

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.

@en

P2093

A J M Nieuweboer

http://www.w3.org/2001/XMLSchema#string

A Sparreboom

http://www.w3.org/2001/XMLSchema#string

A-J M de Graan

http://www.w3.org/2001/XMLSchema#string

F A L M Eskens

http://www.w3.org/2001/XMLSchema#string

J W M Martens

http://www.w3.org/2001/XMLSchema#string

M Smid

http://www.w3.org/2001/XMLSchema#string

P Hamberg

http://www.w3.org/2001/XMLSchema#string

P de Bruijn

http://www.w3.org/2001/XMLSchema#string

R H J Mathijssen

http://www.w3.org/2001/XMLSchema#string

R H N van Schaik

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen sulfotransferase/SULT1E1 promotes human adipogenesis

Identification of a novel human glutathione S-transferase using bioinformatics

The impact of CDA A79C gene polymorphisms on the response and hematologic toxicity in gemcitabine-treated patients: a meta-analysis.

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel.

Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer.

Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.

Pharmacogenetic pathway analysis of docetaxel elimination.

Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.

Peripheral neuropathy induced by microtubule-stabilizing agents.

P2888

tpj.2015.66

P304

519-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TPJ.2015.66

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281623797

http://www.w3.org/2001/XMLSchema#string

P698

26345519

http://www.w3.org/2001/XMLSchema#string